Stock Events

Stock Events

Search...

Brainstorm Cell Therapeutics (BCLI) Q3 2023 Earnings

14NovConfirmed

Q4 2022

Q1 2023

Q2 2023

Q3 2023

-0.16

-0.12

-0.07

-0.03

Details

Expected EPS

-0.14

Actual EPS

-0.03

Surprise EPS

0.11

Surprise Percent

+78.57%

Description

Brainstorm Cell Therapeutics (BCLI) has reported earnings of -0.03 per share for Q3 2023.

0 Comments

Share your thoughts

Get the Stock Events App

Sign up for a Stock Events account to create your own watchlists and track your portfolio or dividends.